Skip to search formSkip to main contentSkip to account menu

Cervagem

Known as: Aventis brand of gemeprost, Cervagème 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Abortifacient Agents, NonsteroidalAlprostadilgemeprost
PG802

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A comparison of lamicel tents and gemeprost (Cervagem) pessaries prior to first trimester abortion
SummaryIn an open, randomized study 108 women were treated with either a Lamicel tent or a 1 mg gemeprost pessary (Cervagem) 4 h… 
1997
1997
Comparative Study of Intravaginal Misoprostol with Gemeprost as an Abortifaeient in Second Trimester Missed Abortion
Summary: This prospective, randomized study compared the efficacy of intravaginal misoprostol (Cytotec) and gemeprost (Cervagem… 
1996
1996
The effect of syntocinon on blood loss during first trimester suction curettage
We have studied 64 pregnant women (9 weeks gestation and greater undergoing elective vaginal termination of pregnancy.) They were… 
1995
1995
Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy
Objective To study the effects of oral mifepristone and vaginal gemeprost on the mechanical properties of the cervix prior to… 
1991
1991
The Use of 16.16‐dimethyl‐PGEl‐ A‐methyl ester (Cervagem) Vaginal Pessaries for Cervical Dilatation Prior to Evacuation for Second Trimester Termination
Summary: The results of a study of 101 consecutive second trimester terminations by Dilatation and Evacuation (D & E) under… 
1990
1990
Clinical effects and cervical tissue changes after treatment with 16,16 dimethyl-trans delta 2 PGE1 methylester in the first trimester.
1988
1988
A comparison of gemeprost (Cervagem) pessaries and Lamicel tents for cervical preparation for abortion by dilatation and suction
Summary. In a randomized, single‐blind trial, 78 women having vaginal termination of pregnancy were treated with either a 1‐mg… 
1988
1988
Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
1985
1985
Midtrimester termination of pregnancy using intravaginal gemeprost (16, 16 dimethyl-trans delta 2 PGE1 methyl ester, cervagem).
The efficacy of a new prostaglandin E, analogue, gemeprost (cervagem) for mid -trimester termination of pregnancy was assessed… 
1984
1984
Controlled study of 16,16‐dimethyl‐trans‐δ2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies
Summary. A pessary containing the prostaglandin analogue, 16,16‐dimethyl‐trans‐δ2prostaglandin El methyl ester (Cervagem) was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)